CJM112 - Novartis
vunakizumab (SHR-1314) - Jiangsu Hengrui Pharma
simepdekinra (LY4100511) - Eli Lilly
izokibep (ABY-035) - ACELYRIN
Jinlixi (xeligekimab) - Zhixiang (Shanghai) Pharma
sonelokimab (M1095) - Avillion, MoonLake Immunotherap
Efleira (netakimab) - Biocad
LY4100504 - Eli Lilly
LP0200 - LEO Pharma
XKH004 - Kanova Biopharma, Livzon Pharma
gumokimab (AK111) - Akesobio
JS005 - Shanghai Junshi Biosci
http://www.ncbi.nlm.nih.gov/pubmed/39982633
 
Dahyeon Kim; Jashin J Wu; Minka Gill; Mireya Cervantes; Nickoulet Babaei; Seanna Yang
 
Feb 21, 2025
 
Next